Investigation of Akt as a Therapeutic Target for Asxl1-Mutated Myeloid Malignancies

Project title

以Akt做為ASXL1突變血液腫瘤治療標的之可行性研究

Internal ID

MOST105-2314-B002-185-MY2

Principal Investigator

Start Date

August 1, 2017

End Date

July 31, 2018

Organizations

Partner Organizations

National Science and Technology Council